Wanda Neal

Wanda Neal serves as a key procurement lead within the National Cancer Institute, supporting the agency’s mission to accelerate cancer research through advanced scientific infrastructure and diagnostic technologies. She manages complex acquisitions in computational biology, data analytics, and laboratory automation services, ensuring alignment with NCI’s strategic priorities in genomic analysis and precision medicine. Her portfolio primarily encompasses IT-enabled research support services, with a strong emphasis on high-performance computing, bioinformatics platforms, and clinical data management systems that enable large-scale translational research. Neal maintains a consistent working relationship with Roche Diagnostics Corporation, a leading provider of molecular diagnostics and laboratory information systems, reflecting a preference for established industry partners with proven capabilities in scalable, compliant research solutions. Her contracting patterns indicate a reliance on vendors with deep domain expertise in oncology data pipelines, next-generation sequencing support, and AI-driven analytical tools, often requiring stringent regulatory and data security compliance under HIPAA and CLIA frameworks. There is no preference for socioeconomic set-asides; all acquisitions are conducted under full and open competition, indicating a focus on technical merit and capability over socioeconomic criteria. This approach underscores a mission-driven priority to secure the highest-performing solutions without restriction, ensuring rapid deployment of critical research infrastructure. Her procurement activity is concentrated under NAICS 541519 (Other Computer Related Services), reflecting a specialization in custom software development, data integration services, and cloud-based research platforms tailored to cancer genomics. She consistently procures services that support high-throughput sequencing data analysis, real-time clinical trial monitoring, and interoperable laboratory information systems, demonstrating deep technical fluency in the intersection of biomedical research and enterprise IT.